Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis

Published:2023-05-31 Issue:8 Volume:47 Page:677-685
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

Tan Bryan,Pan Xin-Hui,Chew Han Shi Jocelyn,Goh Rachel Sze Jen,Lin Chaoxing,Anand Vickram Vijay,Lee Ethan Cheng Zhe,Chan Kai En,Kong Gwyneth,Ong Christen En Ya,Chung Hui Charlotte,Young Dan Yock,Chan Mark Y.^ORCID,Khoo Chin Meng,Mehta Anurag,Muthiah Mark Dhinesh,Noureddin Mazen,Ng Cheng Han,Chew Nicholas W. S.^ORCID,Chin Yip Han^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://www.nature.com/articles/s41366-023-01321-5.pdf

Reference60 articles.

1. Chong B, Kong G, Shankar K, Chew HSJ, Lin C, Goh R, et al. The global syndemic of metabolic diseases in the young adult population: a consortium of trends and projections from the Global Burden of Disease 2000–2019. Metabolism. 2023;141:155402. https://doi.org/10.1016/j.metabol.2023.155402.

2. Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH, et al. The global burden of metabolic disease: Data from 2000 to 2019. Cell Metab. 2023;35:414–28.e3. https://doi.org/10.1016/j.cmet.2023.02.003.

3. Organisation WH. Obesity and overweight fact sheet. World Health Organisation. Accessed 01/05/2022, 2022. https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight.

4. Kinlen D, Cody D, O’Shea D. Complications of obesity. QJM. 2018;111:437–43. https://doi.org/10.1093/qjmed/hcx152.

5. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American association of clinical endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22:1–203. https://doi.org/10.4158/EP161365.GL.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-09-03

2. Charting New Territories in Obesity Management- Traditional Techniques to Tirzepatide;Endocrine Practice;2024-09

3. Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?;Journal of Diabetes and its Complications;2024-08

4. Efficacy and safety of tirzepatide versus placebo in overweight or obese adults without diabetes: a systematic review and meta-analysis of randomized controlled trials;International Journal of Clinical Pharmacy;2024-07-22

5. Data mining study on adverse events of tirzepatide based on FAERS database;Expert Opinion on Drug Safety;2024-07-15